Patent · US Active

Gene expression markers for colorectal cancer prognosis

US8029995B2 · kind B2 · utility

14Cited by

4References

16Claims

0Family size

Assignees

Genomic Health, Inc. · US
NSABP Foundation, Inc. · US

Inventors

Drew Watson · Los Altos, US
Soonmyung Paik · Pittsburgh, US
Wayne Cowens · Tiburon, US
Joffre B. Baker · Montara, US
Kim Clark · Sunnyvale, US
James Hackett · Via Pasubio, US

Key dates

Filing date	Oct 25, 2010
Grant date	Oct 4, 2011
Priority date	—
Expiry date	Oct 25, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/118
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.